65 results
Page 2 of 4
PREC14A
5d8pad zd
26 May 22
Preliminary proxy with contested solicitation
5:29pm
8-K
EX-10.1
g6bia 8a5ckik4
14 Jun 21
Departure of Directors or Certain Officers
4:23pm
8-K
EX-99.1
j6h8vbdrj9cukz
1 Jun 21
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
7:09am
8-K
EX-10.1
iyj9sf 67lxzoouleg
20 May 20
Departure of Directors or Certain Officers
5:13pm
8-K
EX-2.1
ptnlex
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm
8-K
EX-10.1
ufcuyxw gibg35
22 May 19
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.2
08g56cavaun
25 Apr 19
Alkermes Plc Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-10.1
5is kmwpp
23 May 18
Departure of Directors or Certain Officers
4:09pm